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When an Insect Gets a Bug
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Fungal cyclooligomer depsipeptides exhibit antibiotic, antifungal, herbicidal, insecticidal, and nematicidal activities and inhibit mul-
tidrug-resistance, cancer cell proliferation, and cell motility. In this work, Xu et al. identify the gene encoding the nonribosomal pep-
tide synthetase (NRPS) for beauvericin biosynthesis from the entomopathogen Beauveria bassiana and show that this NRPS uses
unconventional biosynthetic mechanisms. Furthermore, heterologous expression of the beauvericin synthetase in E. coli demon-
strates the feasibility of the heterologous production of a fully elaborated fungal cyclooligomer depsipeptide. Comparative insect in-
fection assays using a beauvericin-nonproducer B. bassiana strain revealed that beauvericin is a bona fide virulence factor that plays
a significant albeit not indispensable role in entomopathogenesis.Zipping the Tetrameric Zipper
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Understanding the myriad ways in which proteins recognize and attach partner proteins is
fundamental to understanding normal cellular processes as well as perturbed states such
as Parkinson’s or Alzheimer’s disease. One common protein-protein interface involves
thread-like ‘‘coiled coils,’’ which form a helices that mutually intertwine. Coiled coils can
include different numbers and sequences of helices. How is assembly with identical or dif-
ferent helices controlled? Deng et al. find here, using model helices that form tetrameric
coiled coils, that the structure with different helices is more stable than the homogeneous
alternatives. This heterospecific tetramer offers a powerful model for understanding an
important protein-protein interface. (Figure credit: Deng et al.)
M1 Aminopeptidases Prototype Testing
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M1 aminopeptidases arewidespread in nature and found in organisms ranging frombacteria
and plants to vertebrates. Despite the fact that aminopeptidases remove only a single N-terminal residue, these enzymes exhibit a va-
riety of important biological functions, e.g., processing of surface antigens, regulation of hypertension, inactivation of signaling pep-
tides, and involvement in tumor angiogenesis. Tholander et al. use leukotriene A4 hydrolase/aminopeptidase as a prototype to study
peptidolysis by these enzymes. The findings provide detailed insights to the active-site chemistry of M1 aminopeptidases and will aid
in development of novel enzyme inhibitors.Altered Cell Wall of Mycobacterium smegmatis
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Mycolic acids are essential, virulence-associated components of the cell enve-
lope of Mycobacterium tuberculosis, the causative agent of tuberculosis. In
this issue, Bhatt et al. describe a mutant strain of Mycobacterium smegmatis
that is defective in the final step of mycolic acid biosynthesis, namely, reduction
of a b-oxo precursor. Surprisingly, this step was not necessary for subsequent
processing and transport of mycolic acids, as the mutant strain incorporated
the nonreduced precursor in the cell wall. Biological consequences included in-
creased sensitivity to hydrophobic antibiotics like rifampicin and altered colony
morphology with the implications for the reductase involved for use as a ‘‘sec-
ondary’’ drug target and a possible role in virulence in M. tuberculosis. (Figure-
credits: Bhatt et al.)Importin a/b Pathway Maxed Out
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Nuclear import of many nuclear proteins is mediated through the classical importin a/b pathway. Kosugi et al. report the development
of efficient and specific inhibitors for this transport pathway using a novel method of peptide inhibitor design. Amino acid sequence
design using an activity-based profile of a nuclear localization signal generated two peptides that bound to the full-length importin
a with Kd values in the picomolar range. The high affinity of these peptides, called bimax1 and bimax2, led to formation of a stable
complex with importin a, which was resistant to cargo release activities in the nucleus, and resulted in specific inhibition of the im-
portin a/b pathway.
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Macrolide antibiotics are a class of valuable anti-infective agents that include a macro-
lactone ring, at least one appended sugar unit, and additional hydroxyl and/or epoxide
groups installed by cytochrome P450 enzymes. These functional groups not only con-
tribute to structural diversification, but often improve the bioactivity of resulting prod-
ucts. Herein, Anzai et al. have characterized in vitro two important P450 enzymes
from the mycinamicin biosynthetic pathway of Micromonospora griseorubida. The
work described enhances understanding of macrolide antibiotic production by micro-
organisms and benefits future work on creating novel antibiotics to fight against emerg-
ing infectious diseases with multi-drug-resistance pathogens. (Figure credits: Anzai
et al.)
Cystatin C Hijacked by IdeS
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The protease inhibitor cystatin C is considered the physiologically most important
emergency inhibitor of cysteine protease activity. The present study by Vincents
et al. reveals a novel and unexpected role for cystatin C in stimulating, rather than counteracting, protease activity. Kinetic studies
show that cystatin C efficiently accelerates the enzymatic velocity of the streptococcal papain-like cysteine protease IdeS. This
finding is the first report of a protease inhibitor that accelerates the activity of its putative target protease and a unique example
of how a host protease inhibitor is ‘‘hijacked’’ by a bacterial protease to increase its activity.Human TGM-2 under Attack
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A tissue transglutaminase (TGM-2) catalyzes the formation of either inter- or intramolecular covalent bonds between a protein-bound
glutamine and lysine residues. The TGM-2 crosslinking reaction contributes to neurodegeneration in polyglutamine repeat disorders.
Lai et al. identified chemical inhibitors to TGM-2 and found them to be active in treating polyglutamine-mediated neurodegeneration
disease in Drosophila. These inhibitors serve as valuable lead compounds for the development of orally active TGM-2 inhibitors.
Since these inhibitors have been approved for human use, expectation is that they will accelerate the development of TGM-2
inhibitors.Evolving Tight Couples
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The protein streptavidin (SA) is one of the most widely used proteins in molecular bi-
ology, biotechnology, and, most recently, nanotechnology. Levy and Ellington have
developed and implemented an in vitro compartmentalization (IVC) selection
scheme for the identification of streptavidin variants with altered specificities for
the biotin analogs. These methods should prove useful for generating a variety of
novel SA reagents and for evolving other extremely high-affinity protein:ligand cou-
ples. (Figure adapted from Levy and Ellington)Efficacious Antifungal Agents Targeting DHFR
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Candida glabrata is a lethal fungal pathogen that is resistant to many clinically available antifungal agents. In order to discover drug
leads forC. glabrata, Liu et al. screened a class of propargyl-linked antifolates that are inhibitors of the essential enzyme dihydrofolate
reductase (DHFR) and identified several with modest potency. Additionally, the authors determined a high resolution structure of
C. glabrataDHFR bound to one of these antifolates. Using the structure, they designed and synthesized second generation inhibitors
with high affinity and selectivity for the pathogenic enzyme. The new compounds potently inhibit the growth of the fungus without
overt toxicity to human cells.
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